Skip to content
52
For organizationsPricingSign in

Connections

AB 824

9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to
Sponsors1 cosponsor more
Jim WoodCalifornia lawmaker · D

AB 824

Business: preserving access to affordable drugs

California · Became law

Open page
Lobbied on it8 of 34
Amgen4 reportsAssociation for Accessible Medicines (Aam)4 reportsAstellas Pharma US, Inc.4 reportsUnited Healthcare Services, Inc.4 reportsViatris Inc.4 reportsBayer U.S. LLC3 reportsBiocom California3 reportsBoehringer Ingelheim Pharmaceuticals, Inc.3 reports
AB 824: the one sponsors and 8 of 34 groups that lobbied on it. Point at anyone to see how they are linked.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of AB 824
Jim WoodSponsorsJim Wood sponsored AB 824.None
AmgenLobbied on itAmgen named AB 824 in 4 lobbying reports.4 reports
Association for Accessible Medicines (Aam)Lobbied on itAssociation for Accessible Medicines (Aam) named AB 824 in 4 lobbying reports.4 reports
Astellas Pharma US, Inc.Lobbied on itAstellas Pharma US, Inc. named AB 824 in 4 lobbying reports.4 reports
United Healthcare Services, Inc.Lobbied on itUnited Healthcare Services, Inc. named AB 824 in 4 lobbying reports.4 reports
Viatris Inc.Lobbied on itViatris Inc. named AB 824 in 4 lobbying reports.4 reports
Bayer U.S. LLCLobbied on itBayer U.S. LLC named AB 824 in 3 lobbying reports.3 reports
Biocom CaliforniaLobbied on itBiocom California named AB 824 in 3 lobbying reports.3 reports
Boehringer Ingelheim Pharmaceuticals, Inc.Lobbied on itBoehringer Ingelheim Pharmaceuticals, Inc. named AB 824 in 3 lobbying reports.3 reports